Community pharmacy detection of erectile dysfunction in men with risk factors or who seek treatment or advice but lack a valid prescription.

Introduction: Pharmacists may be the first health care contact consulted about erectile dysfunction (ED).

Aim: To assess pharmacists' ability to detect ED and encourage patients to seek medical evaluation.

Methods: This observational study conducted in Greece and Spain included men without a valid prescription for an ED medication but with a history indicating ED risk and/or who consulted a pharmacist about ED.

The EPIFARM study: an observational study in 574 community pharmacies in Spain characterizing patient profiles of men asking for erectile dysfunction medication.

Introduction: Community pharmacists may be an important first point of contact for erectile dysfunction (ED) patients, but to date there are no reports of the characteristics of men approaching pharmacists for ED advice or treatment.

Aim: To characterize the profiles of men with and without phosphodiesterase-5 inhibitors (PDE5i) prescription asking for ED treatment at the pharmacy.

Methods: A multicenter, observational, cross-sectional study was conducted in Spanish community pharmacies September-November 2008.

Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.

Introduction: Erectile dysfunction (ED) has been associated with several comorbidities and can cause significant loss of quality of life and self-esteem.

Aim: In men with ED, to use the validated Self-Esteem and Relationship (SEAR) questionnaire to evaluate changes in self-esteem associated with sildenafil treatment of ED and to assess changes dependent on concomitant comorbid conditions.

Methods: This was a 14-week, international, randomized, parallel-group, double-blind, flexible-dose (25, 50, or 100 mg), placebo-controlled study of sildenafil in men aged >or=18 years with a clinical diagnosis of ED (score View Article and Find Full Text PDF

[Cultural adaptation to Spanish and validation of the Gastrointestinal Short Form Questionnaire].

Objective: To describe the process followed for the cultural and psychometric adaptation (validation) to Spanish of the Gastrointestinal Short Form Questionnaire (GSFQ), used to measure the interference of symptoms of gastroesophageal reflux disease GERD and to report the psychometric properties of this instrument.

Material And Methods: The adaptation process was supervised by a five-member expert panel. After forward and backward translations in duplicate, a Spanish version was obtained, which was administered to two samples; a five-patient pilot sample to check comprehension and face validity, and a 4,000-patient sample to check structural validity (factor analysis and reliability), construct validity, and discriminative validity.